SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-136643
Filing Date
2021-11-10
Accepted
2021-11-10 08:08:25
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2132440d1_8k.htm   iXBRL 8-K 28771
2 EXHIBIT 99.1 tm2132440d1_ex99-1.htm EX-99.1 69554
6 GRAPHIC tm2132440d1_ex99-1img001.jpg GRAPHIC 3747
  Complete submission text file 0001104659-21-136643.txt   291681

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20211110.xsd EX-101.SCH 3192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20211110_lab.xml EX-101.LAB 35276
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20211110_pre.xml EX-101.PRE 23151
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2132440d1_8k_htm.xml XML 3786
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 211394519
SIC: 2834 Pharmaceutical Preparations